Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1751 - 1775 of 6807 in total
Pacific ocean perch allergenic extract is used in allergenic testing.
Approved
Solenopsis invicta allergenic extract is used in allergenic testing.
Approved
Magnesium silicate is a compound of magnesium oxide and silicon. It is the magnesium salt of silicic acid containing an unspecified amount of water. The molecular formula can be expressed more clearly as MgSiO3.xH2O. It is known as talc and it presents many uses in the cosmetic industry, food industry...
Approved
Pisum sativum whole allergenic extract is used in allergenic testing.
Approved
Alverine is a smooth muscle relaxant used to relieve cramps or spasms of the stomach and intestines. It is therefore useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain.
Approved
Investigational
Lebrikizumab is a monoclonal antibody against IL-13 that binds to a different epitope compared tralokinumab.[A262874,A262879] On November 17, 2023, lebrikizumab was approved by the EMA under the brand name EBGLYSS for the treatment of moderate-to-severe atopic dermatitis in adult and adolescent patients 12 years and older with a body weight...
Approved
Investigational
Cavia porcellus skin or pelt is used in allergenic testing.
Approved
Pinus strobus pollen is the pollen of the Pinus strobus plant. Pinus strobus pollen is mainly used in allergenic testing.
Approved
Agave sisalana fiber is used in allergenic testing.
Approved
Lactuca sativa whole allergenic extract is used in allergenic testing.
Approved
Delamanid is an anti-tuberculosis agent derived from the nitro-dihydro-imidazooxazole class of compounds that inhibits mycolic acid synthesis of bacterial cell wall . It is used in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis (TB) in a combination regimen. Emergence of multidrug-resistant and extensively drug-resistant tuberculosis creates clinical challenges for...
Approved
Investigational
Approved
Experimental
Glycyrrhizic acid is extracted from the root of the licorice plant; Glycyrrhiza glabra. It is a triterpene glycoside with glycyrrhetinic acid that possesses a wide range of pharmacological and biological activities. When extracted from the plant, it can be obtained in the form of ammonium glycyrrhizin and mono-ammonium glycyrrhizin. Glycyrrhizic...
Approved
Experimental
Butobarbital is a sedative and a hypnotic drug.
Approved
Illicit
Ticagrelor, or AZD6140, was first described in the literature in 2003.[A204170,A2903] Ticagrelor is an ADP derivative developed for its P2Y12 receptor antagonism. Unlike clopidogrel, ticagrelor is not a prodrug. It is marketed by Astra Zeneca as Brilinta in the US and Brilique or Possia in the EU, . Ticagrelor was...
Approved
Ocimum tenuiflorum top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Indian frankincense is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Investigational
Salix discolor pollen is the pollen of the Salix discolor plant. Salix discolor pollen is mainly used in allergenic testing.
Approved
Sitotroga cerealella allergenic extract is used in allergenic testing.
Approved
Northern brown shrimp allergenic extract is used in allergenic testing.
Approved
Azlocillin is a semisynthetic ampicillin-derived acylureido penicillin.
Approved
A topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc.
Approved
Matched Iupac: … (1S,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-10-hydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H …
Hormone receptor (HR) positive, especially estrogen receptor-positive, HER2-negative breast cancer is the most common subtype of metastatic breast cancer, resulting in more than 400,000 deaths annually. Although endocrine-based therapy is the first line of treatment, resistance eventually emerges, leaving chemotherapy the only but often ineffective treatment left. Therefore, significant research...
Approved
Investigational
Matched Description: … locally advanced or metastatic breast cancer with one or more alterations in PIK3CA/AKT1/PTEN gene(s) …
Displaying drugs 1751 - 1775 of 6807 in total